Curis
CRIS
#10359
Rank
A$25.89 M
Marketcap
A$0.66
Share price
-0.99%
Change (1 day)
-82.38%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): A-$5.79

According to Curis's latest financial reports the company's current EPS (TTM) is A-$5.20. In 2024 the company made an earnings per share (EPS) of A-$9.97 an increase over its 2023 EPS that were of A-$12.80.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.79-41.92%
2024A-$9.97-22.15%
2023A-$12.80-26.17%
2022A-$17.3422.3%
2021A-$14.18-25.37%
2020A-$18.99-30.93%
2019A-$27.50-2.02%
2018A-$28.07
2016A-$63.79-10%
2015A-$70.88138.1%
2014A-$29.7740%
2013A-$21.26-25%
2012A-$28.3566.67%
2011A-$17.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.86-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$5.05-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.51-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$4.44-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$5.51 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$15.93 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.00-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA